Modalities for reducing interleukin 1 activity in disease.

[1]  U. Andersson,et al.  Lipopolysaccharide induces human interleukin‐1 receptor antagonist and interleukin‐1 production in the same cell , 1992, European journal of immunology.

[2]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[3]  C. March,et al.  Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.

[4]  L. Moldawer,et al.  Type I IL-1 receptor blockade exacerbates murine listeriosis. , 1992, Journal of immunology.

[5]  V. Barak,et al.  Effect of M20 interleukin-1 inhibitor on normal and leukemic human myeloid progenitors , 1992 .

[6]  T. Barbui,et al.  Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. , 1991, Blood.

[7]  C. Dinarello,et al.  Production of interleukin-1-receptor antagonist during experimental endotoxaemia , 1991, The Lancet.

[8]  J. Cavaillon,et al.  Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.

[9]  J. Symons,et al.  Purification and characterization of a novel soluble receptor for interleukin 1 , 1991, The Journal of experimental medicine.

[10]  W. Arend.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. , 1991, The Journal of clinical investigation.

[11]  R. Thompson,et al.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today.

[12]  Z. Estrov,et al.  Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity , 1991 .

[13]  W. Arend,et al.  IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. , 1991, Journal of immunology.

[14]  P. Weber,et al.  Cardiovascular Effects of ω3 Fatty Acids , 1991 .

[15]  S. Waugh,et al.  Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. , 1991, Journal of immunology.

[16]  S. Dower,et al.  Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. , 1990, Science.

[17]  A. Vander,et al.  In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta. , 1990, Cytokine.

[18]  P. Bossù,et al.  Differential activity of interleukin 1α and interleukin 1β in the stimulation of the immune response in vivo , 1990 .

[19]  C. Dinarello,et al.  Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type. , 1988, The Journal of clinical investigation.

[20]  T. Ikejima,et al.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.

[21]  P. Libby,et al.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. , 1988, The Journal of clinical investigation.

[22]  R. Neta,et al.  Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. , 1988, Journal of immunology.

[23]  E. Vellenga,et al.  Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. , 1987, Blood.

[24]  A. Mantovani,et al.  Prostacyclin synthesis induced in vascular cells by interleukin-1. , 1985, Science.

[25]  J. Dayer,et al.  Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants. , 1992, Cytokine.

[26]  C. Schiffer,et al.  Prevention of alloimmunization against platelets. , 1991, Blood.

[27]  M. Klempner,et al.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. , 1989, The New England journal of medicine.